Jiangsu Apon Medical Technology Co Ltd Class A
Jiangsu Apon Medical Technology Co., Ltd. engages in the research and development, production, and sale of medical devices in China. The company's principal products include microcomputer injection pumps, disposable injection pumps, wireless analgesia management systems, and pulse oximeters, as well as medical devices, such as sensors in the field of pain management and nasal care sprayers. Jiang… Read more
Jiangsu Apon Medical Technology Co Ltd Class A (300753) - Net Assets
Latest net assets as of September 2025: CN¥686.08 Million CNY
Based on the latest financial reports, Jiangsu Apon Medical Technology Co Ltd Class A (300753) has net assets worth CN¥686.08 Million CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥839.64 Million) and total liabilities (CN¥153.56 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥686.08 Million |
| % of Total Assets | 81.71% |
| Annual Growth Rate | 24.15% |
| 5-Year Change | -4.32% |
| 10-Year Change | 386.83% |
| Growth Volatility | 40.04 |
Jiangsu Apon Medical Technology Co Ltd Class A - Net Assets Trend (2014–2024)
This chart illustrates how Jiangsu Apon Medical Technology Co Ltd Class A's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Jiangsu Apon Medical Technology Co Ltd Class A (2014–2024)
The table below shows the annual net assets of Jiangsu Apon Medical Technology Co Ltd Class A from 2014 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥707.86 Million | +1.53% |
| 2023-12-31 | CN¥697.20 Million | +1.58% |
| 2022-12-31 | CN¥686.36 Million | -12.06% |
| 2021-12-31 | CN¥780.52 Million | +5.50% |
| 2020-12-31 | CN¥739.84 Million | +9.63% |
| 2019-12-31 | CN¥674.88 Million | +10.02% |
| 2018-12-31 | CN¥613.39 Million | +119.55% |
| 2017-12-31 | CN¥279.38 Million | +21.69% |
| 2016-12-31 | CN¥229.59 Million | +57.90% |
| 2015-12-31 | CN¥145.40 Million | +78.68% |
| 2014-12-31 | CN¥81.37 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Jiangsu Apon Medical Technology Co Ltd Class A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 412.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥190.03 Million | 27.16% |
| Common Stock | CN¥126.05 Million | 18.02% |
| Other Comprehensive Income | CN¥53.67 Million | 7.67% |
| Other Components | CN¥329.90 Million | 47.15% |
| Total Equity | CN¥699.66 Million | 100.00% |
Jiangsu Apon Medical Technology Co Ltd Class A Competitors by Market Cap
The table below lists competitors of Jiangsu Apon Medical Technology Co Ltd Class A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Chengdu Bright Eye Hospital Co. Ltd.
SHE:301239
|
$339.26 Million |
|
Grupo Nacional Provincial S.A.B
MX:GNP
|
$339.34 Million |
|
SK Networks Co Ltd
KO:001740
|
$339.37 Million |
|
JPPPF
PINK:JPPPF
|
$339.45 Million |
|
Universal Store Holdings Ltd
AU:UNI
|
$339.18 Million |
|
Shenzhen Sunmoon Microelectronics Co. Ltd. A
SHG:688699
|
$339.10 Million |
|
Shandong Shanda Oumasoft CO.LTD.
SHE:301185
|
$339.09 Million |
|
NovaBridge Biosciences
NASDAQ:NBP
|
$338.96 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Jiangsu Apon Medical Technology Co Ltd Class A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 696,203,000 to 699,659,000, a change of 3,456,000 (0.5%).
- Net income of 10,801,000 contributed positively to equity growth.
- Dividend payments of 9,649,000 reduced retained earnings.
- Other comprehensive income increased equity by 53,673,010.
- Other factors decreased equity by 51,369,010.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥10.80 Million | +1.54% |
| Dividends Paid | CN¥9.65 Million | -1.38% |
| Other Comprehensive Income | CN¥53.67 Million | +7.67% |
| Other Changes | CN¥-51.37 Million | -7.34% |
| Total Change | CN¥- | 0.50% |
Book Value vs Market Value Analysis
This analysis compares Jiangsu Apon Medical Technology Co Ltd Class A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.09x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 18.17x to 6.09x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | CN¥1.86 | CN¥33.82 | x |
| 2015-12-31 | CN¥1.12 | CN¥33.82 | x |
| 2016-12-31 | CN¥2.38 | CN¥33.82 | x |
| 2017-12-31 | CN¥2.89 | CN¥33.82 | x |
| 2018-12-31 | CN¥6.42 | CN¥33.82 | x |
| 2019-12-31 | CN¥5.35 | CN¥33.82 | x |
| 2020-12-31 | CN¥5.87 | CN¥33.82 | x |
| 2021-12-31 | CN¥6.18 | CN¥33.82 | x |
| 2022-12-31 | CN¥5.44 | CN¥33.82 | x |
| 2023-12-31 | CN¥5.53 | CN¥33.82 | x |
| 2024-12-31 | CN¥5.55 | CN¥33.82 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Jiangsu Apon Medical Technology Co Ltd Class A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.54%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.67%
- • Asset Turnover: 0.47x
- • Equity Multiplier: 1.23x
- Recent ROE (1.54%) is below the historical average (12.91%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 40.51% | 26.08% | 1.04x | 1.49x | CN¥23.64 Million |
| 2015 | 20.49% | 18.82% | 0.85x | 1.28x | CN¥14.80 Million |
| 2016 | 21.30% | 24.06% | 0.67x | 1.32x | CN¥25.31 Million |
| 2017 | 21.31% | 23.46% | 0.74x | 1.23x | CN¥30.74 Million |
| 2018 | 11.59% | 23.52% | 0.43x | 1.14x | CN¥9.60 Million |
| 2019 | 15.16% | 26.96% | 0.50x | 1.12x | CN¥34.85 Million |
| 2020 | 13.11% | 21.88% | 0.54x | 1.12x | CN¥23.01 Million |
| 2021 | 6.93% | 11.72% | 0.51x | 1.15x | CN¥-23.90 Million |
| 2022 | -11.14% | -23.59% | 0.37x | 1.27x | CN¥-144.94 Million |
| 2023 | 1.19% | 1.96% | 0.49x | 1.23x | CN¥-61.34 Million |
| 2024 | 1.54% | 2.67% | 0.47x | 1.23x | CN¥-59.16 Million |
Industry Comparison
This section compares Jiangsu Apon Medical Technology Co Ltd Class A's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,762,135,461
- Average return on equity (ROE) among peers: 25.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Jiangsu Apon Medical Technology Co Ltd Class A (300753) | CN¥686.08 Million | 40.51% | 0.22x | $339.26 Million |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $1.81 Billion | -5.52% | 1.04x | $356.80 Million |
| Blue Sail Medical Co Ltd (002382) | $158.41 Million | 38.73% | 1.07x | $745.86 Million |
| Andon Health Co Ltd (002432) | $20.02 Billion | 80.05% | 0.09x | $2.11 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $1.02 Billion | 24.36% | 0.86x | $344.01 Million |
| Guangzhou Improve Med Instrument (300030) | $592.55 Million | 4.90% | 0.10x | $241.31 Million |
| Shanghai Tofflon Science Tech (300171) | $331.97 Million | 43.03% | 1.51x | $779.91 Million |
| Truking Technology Ltd (300358) | $1.52 Billion | 10.10% | 0.57x | $547.56 Million |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $1.33 Billion | 15.49% | 0.52x | $438.45 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $574.90 Million | 6.24% | 0.48x | $1.63 Billion |
| Autek China Inc (300595) | $253.53 Million | 34.99% | 0.17x | $1.23 Billion |